Novo Nordisk A S annual free cash flow
2019
2020
2021
2022
2023
2024
2025
Novo Nordisk A S Free Cash Flow (FCF) History (NVO)
Novo Nordisk A S reported kr58.96B in free cash flow for fiscal 2025, a decrease of 20.11% from the previous fiscal year, with a free cash flow margin of 19.08%.
View full Novo Nordisk A S company overviewNovo Nordisk A S free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | kr58.96B | −kr14.84B | −20.11% | +19.08% |
| 2024 | 2024-12-31 | kr73.80B | −kr9.30B | −11.19% | +25.41% |
| 2023 | 2023-12-31 | kr83.10B | kr16.36B | +24.51% | +35.78% |
| 2022 | 2022-12-31 | kr66.74B | kr18.08B | +37.14% | +37.72% |
| 2021 | 2021-12-31 | kr48.66B | kr2.54B | +5.50% | +34.56% |
| 2020 | 2020-12-31 | kr46.13B | kr8.28B | +21.87% | +36.34% |
| 2019 | 2019-12-31 | kr37.85B | — | — | +31.02% |
Novo Nordisk A S quarterly free cash flow
No reported data
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|
Novo Nordisk A S free cash flow growth trends
Over the last five reported fiscal years, free cash flow grew from kr46.13B to kr58.96B, a compound annual growth rate of 5.03%.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Novo Nordisk A S filings at SEC.gov ↗